bevacizumab

As nouns the difference between terms and bevacizumab

is that terms is while bevacizumab is (pharmacy) a monoclonal antibody used in the treatment of cancer.

is likely misspelled.

has no English definition.

As a noun bevacizumab

is a monoclonal antibody used in the treatment of cancer.

As nouns the difference between bevacizumab and ranibizumab

is that bevacizumab is a monoclonal antibody used in the treatment of cancer while ranibizumab is a monoclonal antibody fragment derived from the same parent murine antibody as bevacizumab, used as an antiangiogenic.

As nouns the difference between cancer and bevacizumab

is that cancer is cancer while bevacizumab is (pharmacy) a monoclonal antibody used in the treatment of cancer.

As nouns the difference between treatment and bevacizumab

is that treatment is the process or manner of treating someone or something while bevacizumab is (pharmacy) a monoclonal antibody used in the treatment of cancer.

As nouns the difference between antibody and bevacizumab

is that antibody is (immunology) a protein produced by b-lymphocytes that binds to a specific antigen while bevacizumab is (pharmacy) a monoclonal antibody used in the treatment of cancer.

As nouns the difference between monoclonal and bevacizumab

is that monoclonal is (immunochemistry) something produced from a single clone, especially a monoclonal antibody while bevacizumab is (pharmacy) a monoclonal antibody used in the treatment of cancer.

As an adjective monoclonal

is (biochemistry) genetically engineered from a single clone; used especially of a protein or antibody.